Cargando…
Serum-free Erythroid Differentiation for Efficient Genetic Modification and High-Level Adult Hemoglobin Production
In vitro erythroid differentiation from primary human cells is valuable to develop genetic strategies for hemoglobin disorders. However, current erythroid differentiation methods are encumbered by modest transduction rates and high baseline fetal hemoglobin production. In this study, we sought to im...
Autores principales: | Uchida, Naoya, Demirci, Selami, Haro-Mora, Juan J., Fujita, Atsushi, Raines, Lydia N., Hsieh, Matthew M., Tisdale, John F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5948232/ https://www.ncbi.nlm.nih.gov/pubmed/29766032 http://dx.doi.org/10.1016/j.omtm.2018.03.007 |
Ejemplares similares
-
Biallelic correction of sickle cell disease‐derived induced pluripotent stem cells (iPSCs) confirmed at the protein level through serum‐free iPS‐sac/erythroid differentiation
por: Haro‐Mora, Juan J., et al.
Publicado: (2020) -
Development of a forward-oriented therapeutic lentiviral vector for hemoglobin disorders
por: Uchida, Naoya, et al.
Publicado: (2019) -
βT87Q-Globin Gene Therapy Reduces Sickle Hemoglobin Production, Allowing for Ex Vivo Anti-sickling Activity in Human Erythroid Cells
por: Demirci, Selami, et al.
Publicado: (2020) -
Definitive hematopoietic stem/progenitor cells from human embryonic stem cells through serum/feeder-free organoid-induced differentiation
por: Demirci, Selami, et al.
Publicado: (2020) -
Correction to: Definitive hematopoietic stem/progenitor cells from human embryonic stem cells through serum/feeder-free organoid-induced differentiation
por: Demirci, Selami, et al.
Publicado: (2020)